Clinical Trial Update: Topical Lactobacillus Crispatus for Skin Barrier Dysfunction in Obesity [NA]

View source ↗

Summary

A completed clinical trial evaluating topical Lactobacillus crispatus for skin barrier dysfunction in obesity, focusing on skin water loss and microbial coloniz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Skin Barrier Dysfunction

Drugs mentioned

• Topical Lactobacillus crispatus (Lactobacillus crispatus)

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Skin Barrier to Water Loss, Microbial Colonization | NA | Status: COMPLETED